Literature DB >> 27738378

Treatment of Autism Spectrum Disorder in Children and Adolescents.

Melissa DeFilippis1, Karen Dineen Wagner1.   

Abstract

Autism spectrum disorder is a diagnosis that includes significant social communication deficits/delays along with restricted patterns of interests and behaviors. The prevalence of this diagnosis has increased over the past few decades, and it is unclear whether this is solely attributable to the increased awareness of milder forms of the disorder among medical providers. The current treatment options for the core symptoms of autism are limited to psychosocial therapies, such as applied behavior analysis. Medications have been most effective in treating the associated behavioral symptoms of autism, though studies have examined potential benefits in some of the core symptoms of autism with certain medications, especially the repetitive behaviors often seen with this diagnosis. Risperidone and aripiprazole are currently the only medications FDA approved for symptoms associated with autism spectrum disorders, targeting the irritability often seen with this diagnosis. Children and adolescents with autism spectrum disorder appear to be more susceptible to adverse effects with medications; therefore, initiation with low doses and titrating very slowly is recommended. Some complementary alternative treatments have been researched as possible treatments in autism, though evidence supporting many of these is very limited.

Entities:  

Keywords:  autism spectrum disorder; psychopharmacology; psychotherapy; treatment

Mesh:

Substances:

Year:  2016        PMID: 27738378      PMCID: PMC5044466     

Source DB:  PubMed          Journal:  Psychopharmacol Bull        ISSN: 0048-5764


  138 in total

1.  Extended-Release Guanfacine for Hyperactivity in Children With Autism Spectrum Disorder.

Authors:  Lawrence Scahill; James T McCracken; Bryan H King; Carol Rockhill; Bhavik Shah; Laura Politte; Roy Sanders; Mendy Minjarez; Jennifer Cowen; Jennifer Mullett; Chris Page; Denise Ward; Yanhong Deng; Sandra Loo; James Dziura; Christopher J McDougle
Journal:  Am J Psychiatry       Date:  2015-08-28       Impact factor: 18.112

Review 2.  Social skills development in children with autism spectrum disorders: a review of the intervention research.

Authors:  Susan Williams White; Kathleen Keonig; Lawrence Scahill
Journal:  J Autism Dev Disord       Date:  2006-12-29

3.  Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.

Authors:  Ronald N Marcus; Randall Owen; George Manos; Raymond Mankoski; Lisa Kamen; Robert D McQuade; William H Carson; Patricia K Corey-Lisle; Michael G Aman
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-06       Impact factor: 2.576

4.  Digestive enzyme supplementation for autism spectrum disorders: a double-blind randomized controlled trial.

Authors:  Sujeeva A Munasinghe; Carolyn Oliff; Judith Finn; John A Wray
Journal:  J Autism Dev Disord       Date:  2010-09

5.  Risperidone and adaptive behavior in children with autism.

Authors:  Susan K Williams; Lawrence Scahill; Benedetto Vitiello; Michael G Aman; L Eugene Arnold; Christopher J McDougle; James T McCracken; Elaine Tierney; Louise Ritz; David J Posey; Naomi B Swiezy; Jill Hollway; Pegeen Cronin; Jaswinder Ghuman; Courtney Wheeler; Domenic Cicchetti; Sara Sparrow
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2006-04       Impact factor: 8.829

6.  Pilot study of a moderate dose multivitamin/mineral supplement for children with autistic spectrum disorder.

Authors:  James B Adams; Charles Holloway
Journal:  J Altern Complement Med       Date:  2004-12       Impact factor: 2.579

7.  Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders.

Authors:  Adam J Guastella; Stewart L Einfeld; Kylie M Gray; Nicole J Rinehart; Bruce J Tonge; Timothy J Lambert; Ian B Hickie
Journal:  Biol Psychiatry       Date:  2009-11-07       Impact factor: 13.382

8.  Increasing speech intelligibility in children with autism.

Authors:  R L Koegel; S Camarata; L K Koegel; A Ben-Tall; A E Smith
Journal:  J Autism Dev Disord       Date:  1998-06

Review 9.  Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorder.

Authors:  Fred Volkmar; Matthew Siegel; Marc Woodbury-Smith; Bryan King; James McCracken; Matthew State
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-02       Impact factor: 8.829

10.  A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.

Authors:  Ronald N Marcus; Randall Owen; Lisa Kamen; George Manos; Robert D McQuade; William H Carson; Michael G Aman
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2009-11       Impact factor: 8.829

View more
  26 in total

1.  Psychosis in a Child with Atypical Autism: A Case Report and a Brief Review of the Association of Psychosis and Autism.

Authors:  Swapnajeet Sahoo; Susanta Kumar Padhy; Neha Singla; Aakanksha Singh
Journal:  Innov Clin Neurosci       Date:  2018-04-01

2.  Shared Features or Co-occurrence? Evaluating Symptoms of Developmental Coordination Disorder in Children and Adolescents with Autism Spectrum Disorder.

Authors:  Haylie L Miller; Gabriela M Sherrod; Joyce E Mauk; Nicholas E Fears; Linda S Hynan; Priscila M Tamplain
Journal:  J Autism Dev Disord       Date:  2021-01-02

3.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

4.  Towards a nanoparticle-based prophylactic for maternal autoantibody-related autism.

Authors:  Amir Bolandparvaz; Rian Harriman; Kenneth Alvarez; Kristina Lilova; Zexi Zang; Andy Lam; Elizabeth Edmiston; Alexandra Navrotsky; Natalia Vapniarsky; Judy Van De Water; Jamal S Lewis
Journal:  Nanomedicine       Date:  2019-07-23       Impact factor: 5.307

Review 5.  Neural circuits regulating prosocial behaviors.

Authors:  Jessica J Walsh; Daniel J Christoffel; Robert C Malenka
Journal:  Neuropsychopharmacology       Date:  2022-06-14       Impact factor: 7.853

6.  TAU ablation in excitatory neurons and postnatal TAU knockdown reduce epilepsy, SUDEP, and autism behaviors in a Dravet syndrome model.

Authors:  Eric Shao; Che-Wei Chang; Zhiyong Li; Xinxing Yu; Kaitlyn Ho; Michelle Zhang; Xin Wang; Jeffrey Simms; Iris Lo; Jessica Speckart; Julia Holtzman; Gui-Qiu Yu; Erik D Roberson; Lennart Mucke
Journal:  Sci Transl Med       Date:  2022-04-27       Impact factor: 19.319

7.  Targeting Gamma-Related Pathophysiology in Autism Spectrum Disorder Using Transcranial Electrical Stimulation: Opportunities and Challenges.

Authors:  Fae B Kayarian; Ali Jannati; Alexander Rotenberg; Emiliano Santarnecchi
Journal:  Autism Res       Date:  2020-05-28       Impact factor: 5.216

Review 8.  The role of clustered protocadherins in neurodevelopment and neuropsychiatric diseases.

Authors:  Erin Flaherty; Tom Maniatis
Journal:  Curr Opin Genet Dev       Date:  2020-07-14       Impact factor: 5.578

9.  A single early-life seizure results in long-term behavioral changes in the adult Fmr1 knockout mouse.

Authors:  Samantha L Hodges; Conner D Reynolds; Suzanne O Nolan; Jessica L Huebschman; James T Okoh; Matthew S Binder; Joaquin N Lugo
Journal:  Epilepsy Res       Date:  2019-08-29       Impact factor: 3.045

Review 10.  What is autism?

Authors:  Priya Joon; Anil Kumar; Milind Parle
Journal:  Pharmacol Rep       Date:  2021-03-10       Impact factor: 3.024

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.